leukemia
Leukemia was first identified by German pathologist Rudolf Virchow in 1847. The cause of leukemia is the abnormal functioning of the hematopoietic tissue in the bone marrow due to mutations in the DNA in the cells. Stem cells in the bone marrow can produce thousands of red and white blood cells every day. Leukemia patients overproduce immature white blood cells, which interferes with other work of the bone marrow, which reduces the bone marrow's ability to produce other blood cells. Leukemia can spread to the lymph nodes, spleen, liver, central nervous system and other organs.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Children and Youth -
Related symptoms:
Tarry stools Enlarged liver and spleen Bleeding gums Bone tenderness Secondary infection -
Concurrent disease:
Related Drugs
Etoposide Injection
Indication: 1. It is mainly used to treat acute myeloid leukemia, with good efficacy and no cross-resistance with commonly used drugs. 2. It can also be used to treat small cell undifferentiated lung cancer, with good efficacy. 3. It can also be used for malignant lymphoma and testicular malignant germ cell tumor, and can be used in combination with cisplatin. 4. It also has certain efficacy on neuroblastoma, choriocarcinoma and ovarian cancer.
Manufacturer:
Fujian Nanshaolin Pharmaceutical Co., Ltd.
Etoposide Injection
Indication: 1. It is mainly used to treat acute myeloid leukemia, with good efficacy and no cross-resistance with commonly used drugs. 2. It can also be used to treat small cell undifferentiated lung cancer, with good efficacy. 3. It can also be used for malignant lymphoma and testicular malignant germ cell tumor, and can be used in combination with cisplatin. 4. It also has certain efficacy on neuroblastoma, choriocarcinoma and ovarian cancer.
Manufacturer:
Fujian Nanshaolin Pharmaceutical Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Shaanxi Traditional Chinese Medicine Research Institute Hantang Pharmaceutical C O., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Zhejiang Jinhua Aotuokang Pharmaceutical Group Inc. Co.
Mercaptopurine
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Mercaptopurine
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Related Ingredients